Flag of the European Union EU Clinical Trials Register Help

Clinical trials for ulcerative colitis

The European Union Clinical Trials Register   allows you to search for protocol and results information on:
  • interventional clinical trials that were approved in the European Union (EU)/European Economic Area (EEA) under the Clinical Trials Directive 2001/20/EC
  • clinical trials conducted outside the EU/EEA that are linked to European paediatric-medicine development

    • EU/EEA interventional clinical trials approved under or transitioned to the Clinical Trial Regulation 536/2014 are publicly accessible through the
    Clinical Trials Information System (CTIS).

    The EU Clinical Trials Register currently displays   44334   clinical trials with a EudraCT protocol, of which   7366   are clinical trials conducted with subjects less than 18 years old.   The register also displays information on   18700   older paediatric trials (in scope of Article 45 of the Paediatric Regulation (EC) No 1901/2006).

    Phase 1 trials conducted solely on adults and that are not part of an agreed paediatric investigation plan (PIP) are not publicly available (see Frequently Asked Questions ).  
     
    Examples: Cancer AND drug name. Pneumonia AND sponsor name.
    How to search [pdf]
    Search Tips: Under advanced search you can use filters for Country, Age Group, Gender, Trial Phase, Trial Status, Date Range, Rare Diseases and Orphan Designation. For these items you should use the filters and not add them to your search terms in the text field.
    Advanced Search: Search tools
     
    412 result(s) found for: ulcerative colitis. Displaying page 5 of 21.
    « Previous 1  2  3  4  5  6  7  8  9  Next» Last»»
    EudraCT Number: 2014-002579-27 Sponsor Protocol Number: UC-GOL Start Date*: 2015-03-03
    Sponsor Name:Istituto Clinico Humanitas
    Full Title: Pilot study on the efficacy of golimumab in the induction and maintenance of clinical and endoscopic remission in patients with steroid-dependent ulcerative colitis.
    Medical condition: active steroid-dependent ulcerative colitis
    Disease: Version SOC Term Classification Code Term Level
    17.1 100000004856 10045365 Ulcerative colitis LLT
    Population Age: Adults Gender: Male, Female
    Trial protocol: IT (Completed)
    Trial results: (No results available)
    EudraCT Number: 2014-000656-29 Sponsor Protocol Number: MK8259-027 Start Date*: 2014-06-13
    Sponsor Name:MSD Belgium BVBA/SPRL
    Full Title: Preference for a prefilled syringe or Smartject™ device for delivering SIMPONI (golimumab) in patients suffering from moderate to severe ulcerative colitis
    Medical condition: Ulcerative Colitis
    Disease: Version SOC Term Classification Code Term Level
    17.1 100000004856 10045365 Ulcerative colitis LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: BE (Completed)
    Trial results: View results
    EudraCT Number: 2021-003023-14 Sponsor Protocol Number: CSUC-02/21 Start Date*: 2021-09-02
    Sponsor Name:InDex Pharmaceuticals AB
    Full Title: Pharmacokinetics of Cobitolimod Enemas in Participants with active Ulcerative Colitis
    Medical condition: Moderate to Severe Active Ulcerative Colitis
    Disease: Version SOC Term Classification Code Term Level
    20.1 100000004856 10045365 Ulcerative colitis LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: SE (Completed)
    Trial results: View results
    EudraCT Number: 2018-004890-28 Sponsor Protocol Number: WI239830 Start Date*: 2019-10-09
    Sponsor Name:DIP. MEDICINA DEI SISTEMI UNIVERSITà DEGLI STUDI DI ROMA TOR VERGATA
    Full Title: (A)nalysis of immunological (VA)riables in ex vivo (T)ofacitinib-treated human biopsies from (A)ctive ulcerative colitis patients to predict clinical (R)esponse (the AVATAR study).
    Medical condition: Ulcerative colitis
    Disease: Version SOC Term Classification Code Term Level
    20.0 100000004856 10045282 UC LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: IT (Trial now transitioned)
    Trial results: (No results available)
    EudraCT Number: 2020-004461-40 Sponsor Protocol Number: IM011-077 Start Date*: 2021-08-04
    Sponsor Name:Bristol-Myers Squibb International Corporation
    Full Title: An Open-label, Multi-center Extension Study to Evaluate the Long-term Safety and Efficacy of BMS-986165 in Participants with Moderate to Severe Crohn’s Disease or Moderate to Severe Ulcerative Colitis
    Medical condition: moderate to severe Crohn’s Disease (CD), moderate to severe Ulcerative Colitis (UC)
    Disease: Version SOC Term Classification Code Term Level
    20.1 10017947 - Gastrointestinal disorders 10045365 Ulcerative colitis LLT
    20.0 10017947 - Gastrointestinal disorders 10011401 Crohn's disease PT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DE (Prematurely Ended) IT (Prematurely Ended) ES (Ongoing) PT (Prematurely Ended) NL (Completed)
    Trial results: View results
    EudraCT Number: 2016-000516-15 Sponsor Protocol Number: 5-ASA/12/2015 Start Date*: 2016-05-30
    Sponsor Name:CONSORZIO UNIVERSITARIO UNIFARM
    Full Title: Intestinal mucosal concentrations from three mesalazine pharmaceutical formulations and correlation with efficacy in patients with mild/moderate ulcerative colitis
    Medical condition: Ulcerative colites
    Disease: Version SOC Term Classification Code Term Level
    20.0 10017947 - Gastrointestinal disorders 10009900 Colitis ulcerative PT
    Population Age: Adults Gender: Male, Female
    Trial protocol: IT (Completed)
    Trial results: View results
    EudraCT Number: 2011-004812-40 Sponsor Protocol Number: D2211C00001 Start Date*: 2012-01-26
    Sponsor Name:AstraZeneca AB
    Full Title: A phase IIa, randomised, double-blind, placebo-controlled, parallel-arm, multicenter study to evaluate the efficacy and safety of tralokinumab (CAT-354), a recombinant human monoclonal antibody dir...
    Medical condition: Ulcerative Colitis
    Disease: Version SOC Term Classification Code Term Level
    14.1 100000004856 10045365 Ulcerative colitis LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DE (Completed) NL (Prematurely Ended) CZ (Completed) IT (Completed) GB (Completed)
    Trial results: View results
    EudraCT Number: 2007-004732-23 Sponsor Protocol Number: EMET 001 Start Date*: 2007-10-22
    Sponsor Name:EMET Pharmaceuticals LLC
    Full Title: A Multicenter, Randomized, Partially Blinded, Placebo Controlled, Parallel Design, Three-Arm, Bioequivalence Study With Clinical Endpoints Comparing Mesalamine Delayed Release Tablets 400mg To The ...
    Medical condition: Mild to moderately active ulcerative colitis
    Disease: Version SOC Term Classification Code Term Level
    9.1 10009900 Colitis ulcerative LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: EE (Completed) LV (Completed) PL (Completed)
    Trial results: (No results available)
    EudraCT Number: 2019-001653-99 Sponsor Protocol Number: I6T-MC-AMBI Start Date*: 2021-01-15
    Sponsor Name:Eli Lilly and Company
    Full Title: A Phase 3b, Randomized, Double-Blind, Parallel-Arm, Placebo- and Active- Controlled Treat-Through Study of Mirikizumab and Vedolizumab in Participants with Moderately to Severely Active Ulcerativ...
    Medical condition: Moderately to Severely Active Ulcerative Colitis
    Disease: Version SOC Term Classification Code Term Level
    20.1 100000004856 10045365 Ulcerative colitis LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: CZ (Completed) LT (Prematurely Ended) DE (Prematurely Ended) FR (Completed) LV (Prematurely Ended) AT (Prematurely Ended) BE (Completed)
    Trial results: View results
    EudraCT Number: 2021-001644-10 Sponsor Protocol Number: D5272C00002 Start Date*: 2022-10-05
    Sponsor Name:AstraZeneca AB
    Full Title: A Phase 2 Open-label, Long-term Extension Safety Study of Brazikumab in Participants with Moderately to Severely Active Ulcerative Colitis (EXPEDITION OLE)
    Medical condition: Ulcerative Colitis
    Disease: Version SOC Term Classification Code Term Level
    20.1 100000004856 10045365 Ulcerative colitis LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DE (Completed) ES (Prematurely Ended) AT (Prematurely Ended) IT (Prematurely Ended) PL (Prematurely Ended) FR (Completed) HU (Prematurely Ended)
    Trial results: View results
    EudraCT Number: 2006-000197-69 Sponsor Protocol Number: AP IBD 02-02 Start Date*: 2006-05-30
    Sponsor Name:AM-Pharma B.V.
    Full Title: A pilot, open-label, multi-center clinical trial to investigate the safety and efficacy of Bovine-Calf Intestinal Alkaline Phosphatase in patients with moderate to severe ulcerative colitis
    Medical condition: Inflammatory Bowel Disease
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: CZ (Completed) IT (Completed)
    Trial results: (No results available)
    EudraCT Number: 2007-005520-32 Sponsor Protocol Number: CUC111342 Start Date*: 2008-10-01
    Sponsor Name:GlaxoSmithKline R&D Ltd
    Full Title: An open label, 7-day repeat dose study to evaluate the pharmacodynamics of SB-656933-AAA in patients with Ulcerative Colitis.
    Medical condition: ulcerative colitis
    Disease: Version SOC Term Classification Code Term Level
    9.1 10045365 Ulcerative colitis LLT
    Population Age: Adults Gender: Male, Female
    Trial protocol: NL (Prematurely Ended)
    Trial results: View results
    EudraCT Number: 2009-013890-16 Sponsor Protocol Number: P06120 Start Date*: 2010-05-28
    Sponsor Name:GEDII - Grupo de Estudo da Doença inflamatória Intestinal
    Full Title: Herica - Histological and Endoscopic evaluation of Remission induced by Infliximab in moderately to severely active ulcerative Colitis Patients
    Medical condition: This national, multi-centre, open-label pilot study will assess the histologic remission in patients with moderate to severe active ulcerative colitis under infliximab treatment who have had an ina...
    Disease: Version SOC Term Classification Code Term Level
    16.0 100000004856 10045365 Ulcerative colitis LLT
    Population Age: Adults Gender: Male, Female
    Trial protocol: PT (Completed)
    Trial results: (No results available)
    EudraCT Number: 2007-005702-49 Sponsor Protocol Number: 2007017 Start Date*: Information not available in EudraCT
    Sponsor Name:Procter & Gamble Pharmaceuticals
    Full Title: A Randomized, Double-blind, Parallel-group Study to Assess the Safety and Efficacy of Asacol® (1.2 to 4.8 g/day) Administered as 400 mg Delayed-release Tablets Given Every 12 Hours for 6 Weeks to C...
    Medical condition: Mildly-to-Moderately Active Ulcerative Colitis in Children and Adolescents
    Disease: Version SOC Term Classification Code Term Level
    11.0 10045365 LLT
    Population Age: Children, Adolescents, Under 18 Gender: Male, Female
    Trial protocol: PL (Completed)
    Trial results: (No results available)
    EudraCT Number: 2020-003556-33 Sponsor Protocol Number: BBT401-UC-005 Start Date*: 2021-04-19
    Sponsor Name:Bridge Biotherapeutics, Inc.
    Full Title: A Randomised, Double-blind, Placebo-controlled Study of Orally Administered BBT-401-1S in Subjects with Moderate to Severe Ulcerative Colitis, Incorporating a Response-Adaptive, Double-blind Extens...
    Medical condition: Moderate to severe ulcerative colitis.
    Disease: Version SOC Term Classification Code Term Level
    20.0 10017947 - Gastrointestinal disorders 10009900 Colitis ulcerative PT
    Population Age: Adults Gender: Male, Female
    Trial protocol: PL (Completed)
    Trial results: View results
    EudraCT Number: 2020-003006-31 Sponsor Protocol Number: ASPIRE Start Date*: 2021-02-08
    Sponsor Name:FONDAZIONE POLICLINICO UNIVERSITARIO AGOSTINO GEMELLI IRCCS UNIVERSITA' CATTOLICA DEL SACRO CUORE
    Full Title: Predictive value of colonic mucosal and synovial tissues profiles for response to JAKs inhibitor in patients affected by ulcerative colitis and concomitant peripheral arthritis
    Medical condition: Ulcerative colitis and concomitant peripheral arthritis
    Disease: Version SOC Term Classification Code Term Level
    20.0 100000004856 10045282 UC LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: IT (Prematurely Ended)
    Trial results: (No results available)
    EudraCT Number: 2020-003420-16 Sponsor Protocol Number: SPRINT Start Date*: 2021-08-11
    Sponsor Name:Instituto Clinico Humanitas
    Full Title: SPRINT: AN OPEN-LABEL, MULTICENTER STUDY TO EVALUATE STEP-UP VS TOP-DOWN TREATMENT ALGORITHMS IN MODERATE TO SEVERE ULCERATIVE COLITIS
    Medical condition: Moderate to severe ulcerative colitis
    Disease: Version SOC Term Classification Code Term Level
    20.1 100000004856 10045365 Ulcerative colitis LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: ES (Ongoing) BE (Prematurely Ended) IT (Prematurely Ended)
    Trial results: (No results available)
    EudraCT Number: 2006-004230-32 Sponsor Protocol Number: CMA-0402-PR-0005 Start Date*: 2007-12-07
    Sponsor Name:Chiesi Farmaceutici SpA
    Full Title: EFFICACY AND SAFETY OF BECLOMETHASONE DIPROPIONATE GASTRO-RESISTANT, PROLONGED RELEASE TABLETS (CHF 1514) COMPARED WITH ORAL PREDNISONE, IN A 8-WEEK TREATMENT PERIOD, IN PATIENTS WITH ACTIVE ULCERA...
    Medical condition: Ulcerative Colitis extending proximally beyond the rectum with bleeding, verified by endoscopic examination
    Disease: Version SOC Term Classification Code Term Level
    9.1 10045365 Ulcerative colitis LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: PL (Completed) ES (Completed) IT (Completed) BE (Completed)
    Trial results: View results
    EudraCT Number: 2013-004278-88 Sponsor Protocol Number: GA28950 Start Date*: 2014-06-19
    Sponsor Name:F. Hoffmann-La Roche Ltd
    Full Title: PHASE III, DOUBLE BLIND, PLACEBO-CONTROLLED, MULTICENTER STUDY OF THE EFFICACY AND SAFETY OF ETROLIZUMAB DURING INDUCTION AND MAINTENANCE IN PATIENTS WITH MODERATE TO SEVERE ACTIVE ULCERATIVE COLIT...
    Medical condition: Ulcerative colitis (UC)
    Disease: Version SOC Term Classification Code Term Level
    20.1 100000004856 10045365 Ulcerative colitis LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: LT (Completed) GR (Completed) DE (Completed) CZ (Completed) DK (Completed) BE (Completed) HU (Completed) AT (Completed) ES (Completed) NL (Completed) IT (Completed) FR (Completed) PL (Completed)
    Trial results: View results
    EudraCT Number: 2006-004776-12 Sponsor Protocol Number: CB-01-02/02 Start Date*: 2008-06-02
    Sponsor Name:COSMO Technologies Ltd
    Full Title: Efficacy and safety of oral budesonide-MMX™ (CB-01-02) 6 mg and 9 mg extended release tablets in patients with mild or moderate active ulcerative colitis. A multicentre, randomised, double-blind, ...
    Medical condition: Mild or moderate active ulcerative colitis.
    Disease: Version SOC Term Classification Code Term Level
    9.1 10045365 Ulcerative colitis LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: SE (Completed) LT (Completed) GB (Completed) LV (Completed) FR (Completed) EE (Completed) BE (Completed) SK (Completed) IT (Completed)
    Trial results: View results
    Download Options:
    Number of Trials to download:
    Download Content:
    Download Format:
    Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial.
    « Previous 1  2  3  4  5  6  7  8  9  Next» Last»»
    Query did not match any studies.
    For support, Contact us.
    The status and protocol content of GB trials is no longer updated since 1 January 2021. For the UK, as of 31 January 2021, EU Law applies only to the territory of Northern Ireland (NI) to the extent foreseen in the Protocol on Ireland/NI. Legal notice
    As of 31 January 2023, all EU/EEA initial clinical trial applications must be submitted through CTIS . Updated EudraCT trials information and information on PIP/Art 46 trials conducted exclusively in third countries continues to be submitted through EudraCT and published on this website.

    European Medicines Agency © 1995-Thu May 08 07:31:48 CEST 2025 | Domenico Scarlattilaan 6, 1083 HS Amsterdam, The Netherlands
    EMA HMA